Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
The U.S. federal and state governments are taking steps to ameliorate the physician shortage by offering scholarship and loan-repayment options to medical students interested in primary care practice in designated underserved areas.